Genomic studies have shown that HPV-negative cervical cancers have different molecular features from HPV-positive tumors, typically characterized by high TP53 and CDKN2A co-mutation rates and increased PTEN mutation frequency [61,62]. The gene discussed is TP53; the disease is cervical cancer.